OIP5 expression is significantly upregulated in pRCC; high levels of OIP5 correlate with adverse clinical characteristics of the disease, including stage, histological subtype (T2P), molecular subtype (CIMP), and lymph node metastasis. This evidence concerns the gene OIP5 and metastatic malignant neoplasm in the lymph nodes.